Article info
PDFClinical ethics
Paper
Settling for second best: when should doctors agree to parental demands for suboptimal medical treatment?
- Correspondence to Tara Nair, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia; trnai1{at}student.monash.edu
Citation
Settling for second best: when should doctors agree to parental demands for suboptimal medical treatment?
Publication history
- Received February 16, 2016
- Revised December 20, 2016
- Accepted June 15, 2017
- First published September 25, 2017.
Online issue publication
November 23, 2017
Article Versions
- Previous version (25 September 2017).
- Previous version (3 October 2017).
- Previous version (6 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
Other content recommended for you
- Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies
- Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care
- Worth living or worth dying? The views of the general public about allowing disabled children to die
- Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004–2018
- Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC
- Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort
- Explaining age-specific inequalities in mortality from all causes, cardiovascular disease and ischaemic heart disease among South Korean male public servants: relative and absolute perspectives
- Rationing and life-saving treatments: should identifiable patients have higher priority?
- Association between biomarkers and COVID-19 severity and mortality: a nationwide Danish cohort study
- Association between routine measures of graft function and mortality in heart transplant recipients